School of Medicine
Showing 1-10 of 13 Results
Aya Kamaya, MD
Associate Professor of Radiology (Body Imaging) at the Stanford University Medical Center
Current Research and Scholarly Interests Hepatobiliary imaging
Novel ultrasound technologies
Perfusion CT imaging of abdominal tumors
Assistant Professor (Research) of Radiology (Musculoskeletal Imaging)
Current Research and Scholarly Interests My research is focused on the development and clinical translation of novel imaging techniques geared toward early detection of musculoskeletal disease. Current projects include whole-joint molecular imaging of early disease with PET-MRI, imaging of early cartilage changes in Osteoarthritis (OA) with GagCEST, rapid knee imaging and simultaneous bilateral knee MRI.
Nishita Kothary, MD
Professor of Radiology (Interventional Radiology) at the Stanford University Medical Center
Current Research and Scholarly Interests Interventional Oncology: Percutaneous and transarterial interventions for diagnosis and treatment of primary and metastatic tumors (lung, liver and renal)
Gastrointestinal and Hepatic Oncology
Clinical Instructor, Radiology
Bio Dr. Karin Kuhn is originally from Tucson, AZ, and practiced as a physical therapist for several years in the Washington DC metro area prior to returning to medical school. Following an internship in preliminary medicine at Kaiser Oakland, she moved to the bay area to pursue dedicated training in diagnostic radiology at Stanford. Following residency, she will continue specialized fellowship training in musculoskeletal radiology at Stanford. Outside of medicine, she is a wife and mother of two with interests in health and fitness, gourmet cooking, and travel.
Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Kummar?s research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Her studies integrate genomics and laboratory correlates into early phase trials. She is interested in alternate trial designs to facilitate rational drug selection based on human data and help expedite drug development timelines. She has published numerous articles in medical journals and serves on a number of national and international scientific committees.